Search Results - "Castellano, Maria Eva Mingot"

Refine Results
  1. 1
  2. 2

    International recommendations on the diagnosis and treatment of patients with acquired hemophilia A by Huth-Kuhne, Angela, Baudo, Francesco, Collins, Peter, Ingerslev, Jorgen, Kessler, Craig M, Levesque, Herve, Castellano, Maria Eva Mingot, Shima, Midori, St-Louis, Jean

    Published in Haematologica (Roma) (01-04-2009)
    “…1 SRH Kurpfalzkrankenhaus Heidelberg gGmbH and Hemophilia Center, Heidelberg, Germany 2 Thrombosis and Hemostasis Unit, Niguarda Hospital, Milan, Italy 3…”
    Get full text
    Journal Article
  3. 3
  4. 4
  5. 5

    BAY 81‐8973 prophylaxis and pharmacokinetics in haemophilia A: Interim results from the TAURUS study by Santoro, Cristina, Fuh, Beng, Le, Phu Quoc, Maes, Philip, Berrueco, Rubén, MingotCastellano, Eva Maria, von Mackensen, Sylvia, Solms, Alexander, Wang, Michael

    Published in European journal of haematology (01-08-2020)
    “…Objectives To report interim data from TAURUS, a study assessing real‐world prophylactic treatment with unmodified, full‐length recombinant FVIII BAY 81‐8973…”
    Get full text
    Journal Article
  6. 6

    Hip Replacement Surgery in 14-Year-Old Girl with Factor V Deficiency: Haemostatic Treatment and Thromboprophylaxis by Mingot-Castellano, María Eva, Baeza-Montañez, Lourdes, Pérez-Núñez, Josefina

    Published in Case reports in hematology (01-01-2016)
    “…Factor V (FV) is a pivotal coagulation factor present in plasma and platelets. It plays an essential role in secondary haemostasis acting as a cofactor in the…”
    Get full text
    Journal Article
  7. 7

    Acquired Haemophilia A: A Review of What We Know by Mingot-Castellano, Maria Eva, Rodriguez-Martorell, Francisco Javier, Nunez-Vazquez, Ramiro Jose, Marco, Pascual

    Published in Journal of blood medicine (30-11-2022)
    “…Autoantibodies against plasma coagulation factors could be developed by some individuals inducing severe and sometimes fatal bleedings. This clinical entity is…”
    Get full text
    Journal Article
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12

    New treatments for primary immune thrombocytopenia by Mingot-Castellano, María Eva

    Published in Blood coagulation & fibrinolysis (01-01-2022)
    “…Primary immune thrombocytopenia (ITP) is an autoimmune disease leading to a decreased platelet count and an ensuing haemorrhagic risk. First-line treatment…”
    Get full text
    Journal Article
  13. 13
  14. 14

    Prophylaxis therapy with bypassing agents in patients with haemophilia A and inhibitors undergoing surgery: A cost analysis in Spain by Mareque, María, MingotCastellano, María Eva, López‐Fernández, María Fernanda, Álvarez‐Román, María Teresa, Oyagüez, Itziar

    Published in European journal of haematology (01-07-2020)
    “…Objectives This study estimated the cost of prophylaxis with activated prothrombin complex concentrate (aPCC) and recombinant activated factor VIIa (rFVIIa) in…”
    Get full text
    Journal Article
  15. 15
  16. 16
  17. 17
  18. 18

    Clinical pattern of hemophilia and causes of variability by Mingot-Castellano, Maria Eva

    Published in Blood coagulation & fibrinolysis (01-09-2019)
    “…In persons with hemophilia, the severity and spontaneity of bleeding episodes depends on the degree of factor deficiency present in the patients. Severe…”
    Get full text
    Journal Article
  19. 19

    Spanish registry of thrombotic thrombocytopenic purpura (REPTT): Data evidence and new developments by Mingot-Castellano, María Eva, Izquierdo, Cristina Pascual, del Rio Garma, Julio

    Published in Transfusion and apheresis science (01-06-2023)
    “…Immuno Thrombotic thrombocytopenic purpura (iTTP) is a rare and potentially fatal disorder characterized by systemic microvascular thrombosis because of a…”
    Get full text
    Journal Article
  20. 20